Repligen (RGEN) Total Liabilities (2011 - 2026)

Repligen (RGEN) has 16 years of Total Liabilities data on file, last reported at $825.3 million in Q1 2026.

• On a quarterly basis, Total Liabilities fell 4.77% year-over-year to $825.3 million in Q1 2026; TTM through Mar 2026 was $825.3 million, a 4.77% decrease from a year earlier, with the FY2025 full-year figure at $843.6 million, down 1.56% from the prior year.
• Total Liabilities for Q1 2026 stood at $825.3 million, down from $843.6 million in the prior quarter.
• Over the last five years, Total Liabilities for RGEN reached as high as $888.1 million in Q1 2024 and fell as low as $549.0 million in Q3 2023.
• Historically, Total Liabilities has averaged $752.9 million across 5 years, with a median of $825.3 million in 2026.
• Across the five-year window, Total Liabilities soared 66.37% in 2022 and fell 12.5% in 2023, its largest moves.
• Year by year, Total Liabilities stood at $620.9 million in 2022, then soared by 39.53% to $866.3 million in 2023, then declined by 1.08% to $856.9 million in 2024, then slipped by 1.56% to $843.6 million in 2025, then dropped by 2.16% to $825.3 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $825.3 million in Q1 2026, $843.6 million in Q4 2025, and $840.6 million in Q3 2025.